MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA

MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA. A presente invenção refere-se a agentes para uso no tratamento ou prevenção de um evento adverso ou doença relacionada à citocina, tal como síndrome de liberação de citocinas (CRS). The disclosure relates to agents for use in the tre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANJAN G. THAKURTA, DANNY VIJEY JEYARAJU, ROSS LA MOTTE-MOHS, MICHAEL AMATANGELO, WILLIAM PIERCEALL
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANJAN G. THAKURTA
DANNY VIJEY JEYARAJU
ROSS LA MOTTE-MOHS
MICHAEL AMATANGELO
WILLIAM PIERCEALL
description MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA. A presente invenção refere-se a agentes para uso no tratamento ou prevenção de um evento adverso ou doença relacionada à citocina, tal como síndrome de liberação de citocinas (CRS). The disclosure relates to agents for use in the treatment or prevention of a cytokine-related adverse event or disease, such as cytokine release syndrome (CRS).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112022020673A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112022020673A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112022020673A23</originalsourceid><addsrcrecordid>eNrjZHD2PdwZ4u_iH6zg4qoQEuQY4ujr6hfiD-K5hoFYwQqOLmGuQcFARpCrj6Ozp7-fI0j54QYFZ88Qf2dPP0ceBta0xJziVF4ozc2g6uYa4uyhm1qQH59aXJCYnJqXWhLvFGRoaGRgBEQGZubGjkbGxKoDAES8Lm8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA</title><source>esp@cenet</source><creator>ANJAN G. THAKURTA ; DANNY VIJEY JEYARAJU ; ROSS LA MOTTE-MOHS ; MICHAEL AMATANGELO ; WILLIAM PIERCEALL</creator><creatorcontrib>ANJAN G. THAKURTA ; DANNY VIJEY JEYARAJU ; ROSS LA MOTTE-MOHS ; MICHAEL AMATANGELO ; WILLIAM PIERCEALL</creatorcontrib><description>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA. A presente invenção refere-se a agentes para uso no tratamento ou prevenção de um evento adverso ou doença relacionada à citocina, tal como síndrome de liberação de citocinas (CRS). The disclosure relates to agents for use in the treatment or prevention of a cytokine-related adverse event or disease, such as cytokine release syndrome (CRS).</description><language>por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230124&amp;DB=EPODOC&amp;CC=BR&amp;NR=112022020673A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230124&amp;DB=EPODOC&amp;CC=BR&amp;NR=112022020673A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANJAN G. THAKURTA</creatorcontrib><creatorcontrib>DANNY VIJEY JEYARAJU</creatorcontrib><creatorcontrib>ROSS LA MOTTE-MOHS</creatorcontrib><creatorcontrib>MICHAEL AMATANGELO</creatorcontrib><creatorcontrib>WILLIAM PIERCEALL</creatorcontrib><title>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA</title><description>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA. A presente invenção refere-se a agentes para uso no tratamento ou prevenção de um evento adverso ou doença relacionada à citocina, tal como síndrome de liberação de citocinas (CRS). The disclosure relates to agents for use in the treatment or prevention of a cytokine-related adverse event or disease, such as cytokine release syndrome (CRS).</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD2PdwZ4u_iH6zg4qoQEuQY4ujr6hfiD-K5hoFYwQqOLmGuQcFARpCrj6Ozp7-fI0j54QYFZ88Qf2dPP0ceBta0xJziVF4ozc2g6uYa4uyhm1qQH59aXJCYnJqXWhLvFGRoaGRgBEQGZubGjkbGxKoDAES8Lm8</recordid><startdate>20230124</startdate><enddate>20230124</enddate><creator>ANJAN G. THAKURTA</creator><creator>DANNY VIJEY JEYARAJU</creator><creator>ROSS LA MOTTE-MOHS</creator><creator>MICHAEL AMATANGELO</creator><creator>WILLIAM PIERCEALL</creator><scope>EVB</scope></search><sort><creationdate>20230124</creationdate><title>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA</title><author>ANJAN G. THAKURTA ; DANNY VIJEY JEYARAJU ; ROSS LA MOTTE-MOHS ; MICHAEL AMATANGELO ; WILLIAM PIERCEALL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112022020673A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANJAN G. THAKURTA</creatorcontrib><creatorcontrib>DANNY VIJEY JEYARAJU</creatorcontrib><creatorcontrib>ROSS LA MOTTE-MOHS</creatorcontrib><creatorcontrib>MICHAEL AMATANGELO</creatorcontrib><creatorcontrib>WILLIAM PIERCEALL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANJAN G. THAKURTA</au><au>DANNY VIJEY JEYARAJU</au><au>ROSS LA MOTTE-MOHS</au><au>MICHAEL AMATANGELO</au><au>WILLIAM PIERCEALL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA</title><date>2023-01-24</date><risdate>2023</risdate><abstract>MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA. A presente invenção refere-se a agentes para uso no tratamento ou prevenção de um evento adverso ou doença relacionada à citocina, tal como síndrome de liberação de citocinas (CRS). The disclosure relates to agents for use in the treatment or prevention of a cytokine-related adverse event or disease, such as cytokine release syndrome (CRS).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112022020673A2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title MÉTODOS DE TRATAMENTO DE EVENTOS ADVERSOS RELACIONADOS À CITOCINA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A32%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANJAN%20G.%20THAKURTA&rft.date=2023-01-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112022020673A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true